Overview
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
Status:
Completed
Completed
Trial end date:
2015-08-01
2015-08-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Azienda Ospedaliera S. Maria della MisericordiaTreatments:
Deslorelin
Triptorelin Pamoate
Criteria
Inclusion Criteria:- submucous myoma diagnosed by vaginal ultrasonography and confirmed by diagnostic
hysteroscopy
- premenopausal status
Exclusion Criteria:
- present or past history of cancer
- pregnancy
- presence of associated multiple polyps
- presence of > 2 myomas
- associated nonhysteroscopic surgical procedures